Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
TECH
#805
Bio-Techne Corp.
59.0
0
+4.93%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+4.93%
Changement Mensuel
-13.21%
Evolution sur 6 mois
+4.93%
Changement Annuel
-3.37%
Clôture Précédente
56.2
3
Open
59.0
0
Bid
Ask
Low
59.0
0
High
59.0
0
Volume
141
Marchés
Actions des Marchés US
Soins de Santé
TECH
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
156.32 M
156.85 M
158.17 M
158.6 M
155.55 M
—
Valuation ratios
Enterprise value
17.41 B
13.42 B
12.73 B
11.21 B
7.84 B
34.44 B
Price to earnings ratio
129.76
52.28
46.38
68.2
111.85
411.33
Price to sales ratio
19.58
12.86
11.62
9.93
6.74
29.43
Price to cash flow ratio
51.76
43.72
51.94
38.51
28.58
136.77
Price to book ratio
11.66
8.36
6.72
5.56
4.03
7.38
Enterprise value to EBITDA ratio
53.55
33.75
31.35
35.19
36.96
149.32
Profitability ratios
Return on assets %
0.06
0.12
0.11
0.06
0.03
0.03
Return on equity %
0.09
0.16
0.15
0.08
0.04
0.04
Return on invested capital %
46.23
51.59
45.92
30.66
12.62
14.19
Gross margin %
67.97
68.42
67.72
66.41
64.8
260.88
Operating margin %
25.49
26.83
26.3
17.83
8.38
39.75
EBITDA margin %
34.91
35.97
35.73
27.47
17.4
73.87
Net margin %
15.08
24.61
25.1
14.5
6.02
27.74
Liquidity ratios
Quick ratio
2.59
2.64
3.5
2.75
2.38
10.85
Current ratio
3.35
3.44
4.84
3.87
3.46
15.92
Inventory turnover
2.71
2.71
2.35
2.22
2.33
2.17
Asset turnover
0.43
0.49
0.46
0.43
0.46
0.47
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.14
—
Long term debt to total equity ratio
—
—
—
—
0.17
—
Per share metrics
Operating cash flow per share
2.17
1.98
1.57
1.86
1.8
1.57
EBIT per share
1.47
1.81
1.85
1.29
0.64
0.74
EBITDA per share
2.01
2.42
2.51
1.98
1.33
1.4
Total debt per share
—
—
—
—
—
—
Cash per share
1.23
1.51
1.26
0.95
1.02
3.92
Net current asset value per share
3.15
3.69
3.84
3.84
3.81
15.68
Tangible book value per share
5.85
2.12
3.45
3.66
4.33
17.44
Working capital per share
2.21
2.62
3.05
2.85
2.71
11.7
Book value per share
9.65
10.37
12.15
12.87
12.76
51.55
Bio-Techne Corp
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Nouvelles
Tracking Ruane, Cunniff, & Goldfarb’s Portfolio – Q4 2025 Update (MUTF:SEQUX)
The CEO of a startup building robots for factories explains how US manufacturing is at a crossroads
Apple and Google employees customized their own Tudor watches. Now they're up for sale.
Blue Owl shopped debt for a CoreWeave data center. Lenders weren't sold.
War rooms, group chats, and video games: Inside Elon Musk's AI startup
TikToker Khaby Lame's $975 million deal is riding on a crashing stock
14 'Second Wave' startups aiming to take the AI era beyond cost cutting
From a tense corporate split to a viral photo: A timeline of Anthropic and OpenAI's budding rivalry
The battle over Scott Adams' AI afterlife
Is taste a 'new core skill'? Techies debate — and quickly get memed
DeepMind's CEO says using AI can make you a genius — or hurt your critical thinking skills
OpenAI offers $15,000 and support resources to staff affected by US immigration authorities